IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype by Loke, P'ng et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IL-4 dependent alternatively-activated macrophages have a
distinctive in vivo gene expression phenotype
Citation for published version:
Loke, P, Nair, MG, Parkinson, J, Guiliano, D, Blaxter, M & Allen, JE 2002, 'IL-4 dependent alternatively-
activated macrophages have a distinctive in vivo gene expression phenotype' BMC Immunology, vol 3, no.
7., 10.1186/1471-2172-3-7
Digital Object Identifier (DOI):
10.1186/1471-2172-3-7
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
BMC Immunology
Publisher Rights Statement:
Verbatim copying and redistribution of this article are permitted in any medium for any purpose, provided
this notice is preserved along with the article's original URL.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
BioMed Central
Page 1 of 11
(page number not for citation purposes)
BMC Immunology
BMC Immunology 2002, 3 xResearch article
IL-4 dependent alternatively-activated macrophages have a 
distinctive in vivo gene expression phenotype
P'ng Loke1,2, Meera G Nair1, John Parkinson1, David Guiliano1, 
Mark Blaxter1 and Judith E Allen*1
Address: 1Institute of Cell, Animal and Population Biology, University of Edinburgh, Edinburgh EH9 3JT, UK and 2Department of Molecular and 
Cell Biology, University of California, Berkeley, CA 94720, USA
E-mail: P'ng Loke - ploke@uclink.berkeley.edu; Meera G Nair - m.g.nair@ed.ac.uk; John Parkinson - john.parkinson@ed.ac.uk; 
David Guiliano - David.Guiliano@ed.ac.uk; Mark Blaxter - mark.blaxter@ed.ac.uk; Judith E Allen* - j.allen@ed.ac.uk
*Corresponding author
Abstract
Background: "Alternatively-activated" macrophages are found in Th2-mediated inflammatory
settings such as nematode infection and allergic pulmonary inflammation. Due in part to a lack of
markers, these cells have not been well characterized in vivo and their function remains unknown.
Results: We have used murine macrophages elicited by nematode infection (NeMφ) as a source
of in vivo derived alternatively activated macrophages. Using three distinct yet complementary
molecular approaches we have established a gene expression profile of alternatively activated
macrophages and identified macrophage genes that are regulated in vivo by IL-4. First, genes
abundantly expressed were identified by an expressed sequence tag strategy. Second, an array of
1176 known mouse genes was screened for differential expression between NeMφ from wild type
or IL-4 deficient mice. Third, a subtractive library was screened to identify novel IL-4 dependent
macrophage genes. Differential expression was confirmed by real time RT-PCR analysis.
Conclusions: Our data demonstrate that alternatively activated macrophages generated in vivo
have a gene expression profile distinct from any macrophage population described to date. Several
of the genes we identified, including those most abundantly expressed, have not previously been
associated with macrophages and thus this study provides unique new information regarding the
phenotype of macrophages found in Th2-mediated, chronic inflammatory settings. Our data also
provide additional in vivo evidence for parallels between the inflammatory processes involved in
nematode infection and allergy.
Background
Macrophages play a crucial role in innate as well as adap-
tive immune responses to pathogens, and are thought to
be critical mediators of many chronic inflammatory dis-
eases [1–4]. During inflammation, the signals that mono-
cytes encounter during migration to the inflammatory site
direct their maturation into macrophages with distinct
phenotypes. The best-studied macrophage phenotype is
the classically-activated macrophage which develops in re-
sponse to pro-inflammatory stimuli such as Th1 cytokines
or bacterial products. Activation of macrophages by bacte-
rial products such as LPS and CpG DNA often occurs as a
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result of engaging receptors of the Toll family [5], leading
to the activation of microbicidal and pro-inflammatory
pathways. The activation status of macrophages can deter-
mine whether infection is resolved successfully or
progresses to a chronic state [6]. Accordingly, live intracel-
lular pathogens such as Leishmania [7,8], Toxoplasma [9]
and Mycobacteria [10] modulate macrophage phenotype
as effective immune evasion strategies.
In contrast to intracellular pathogens, little is known
about the behavior or function of macrophages after ex-
posure to extracellular nematode parasites. Nematodes
generally induce a Th2 cytokine response and as with al-
lergic inflammation, macrophages and eosinophils are
prominent components of the cellular infiltrate associat-
ed with infection. Macrophages that differentiate in the
presence of Th2 cytokines have been called alternatively-
activated macrophages [11] to distinguish them from clas-
sically-activated macrophages. Although IL-4 and IL-13
activated macrophages have been described in several in
vitro systems [12–14], studies describing the recruitment
or activation of these cells in vivo remain scarce. Further-
more, relative to pro-inflammatory Th1 pathways, the in-
fluence of Th2 activation signals or IL-4 on the phenotype
and gene expression profiles of these macrophages is
poorly understood.
We have previously described the induction of an alterna-
tively activated macrophage population in mice implant-
ed intraperitoneally with the filarial nematode Brugia
malayi [15,16]. In these mice, which develop a profound
Th2-type immune response, macrophages and eosi-
nophils are recruited in high numbers to the site of para-
site infection [17]. The composition of the peritoneal
exudate is stable for many weeks with little overt patholo-
gy for the host or damage to the parasite. These nematode
elicited macrophages (NeMφ) thus represent an in vivo
model for macrophages found in chronic inflammatory
settings with high levels of Th2 cell activation. NeMφ pos-
sess several distinctive characteristics, the most striking of
which is the ability to profoundly suppress the prolifera-
tion of other cells with which they are co-cultured [15,16].
The suppressive phenotype of these macrophages is de-
pendent on IL-4 since macrophages recruited in IL-4-defi-
cient mice are not suppressive [15,18]. However, infected
IL-4-deficient mice do not show either increased parasite
burden or pathology [19], suggesting that suppressive
macrophages in this setting are not essential for parasite
survival. Interestingly, when these macrophages are used
as antigen presenting cells to stimulate naïve T cells from
TCR transgenic mice, they induce the differentiation of IL-
4 producing Th2 cells [20].
In this study, we used a combination of EST analysis, ex-
pression array analysis and subtractive hybridization to
establish a profile of IL-4 dependent gene expression in
macrophages associated with nematode infection. Al-
though a recent serial analysis of gene expression (SAGE)
study provided extensive and valuable information re-
garding gene expression by in vitro derived human macro-
phages [21,22], little is known about gene expression in
this functional subset of macrophages that have been ac-
tivated in vivo under potent Th2 conditions. Our analysis
validated that some genes known to be upregulated (e.g.
arginase 1) or suppressed (e.g. MIP-1α, MIP-1β) in vitro by
Th2 cytokines are indeed modulated in an IL-4 dependent
manner in vivo. Importantly, a number of genes were iden-
tified that have not previously been associated with mac-
rophage function. Of significant interest, FIZZ1/RELM-α
[23,24], a resistin homologue recently discovered in a
murine model of asthma [25], was identified as a major
target of IL-4 action in macrophages. These analyses
strengthen the link between allergic inflammation and
helminth infection. In addition they suggest that repro-
gramming of gene expression by IL-4 and marked induc-
tion of novel secreted products such as FIZZ1/RELMα
might define the progression to the chronic state charac-
teristic of these conditions.
Results
EST analysis of suppressive NeMφ
We have previously shown that infection with B. malayi
induces both suppressive macrophages and eosinophils
in WT mice, and that the suppressive phenotype is intact
in IL-5-/- mice [15], in the absence of co-recruitment of
eosinophils. We therefore carried out an EST project by
randomly sequencing clones from a cDNA library con-
structed from F4/80 purified peritoneal macrophages that
were recruited by Brugia malayi into the peritoneal cavity
of IL-5-/- mice. This analysis provided a profile of the most
abundantly expressed genes in the suppressive NeMφ.
From this macrophage library, a total of 651 clones were
sequenced, processed and clustered as described in the
methods. Of these, 244 clones could be grouped into 48
clusters containing two or more sequences. The remaining
407 clones were unique in our dataset. The full dataset is
available at  [http://nema.cap.ed.ac.uk/seq_tables/macro-
phage/macro.html].
This strategy identified a number of very abundantly ex-
pressed genes (Table 1). Strikingly, more than 10% of the
clones that were sequenced encoded a novel eosinophil
chemotactic factor (Ym1/ECF-L) that shares close similar-
ity with chitinases [17,26–28]. The second most abun-
dantly expressed transcript was FIZZ1 [25], a newly
identified gene not previously associated with macro-
phage function. The observation that hepatic arginase 1
was highly expressed was consistent with previous reports
showing that this enzyme is closely associated with alter-
native macrophage activation [29]. Other genes that were
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abundantly expressed included serum amyloid A3 (SAA3,
an acute phase protein [30]); Spα (a secreted scavenger re-
ceptor cysteine-rich protein [31]); C4 complement and Fc
gamma receptor III.
Arginase 1 is an IL-4 dependent gene in vivo
Arginase 1 is an inducible enzyme that metabolizes L-ar-
ginine, and has been shown to be upregulated in a Stat6
dependent manner by the Th2 cytokines IL-4 and IL-13 in
vitro [29,32,33]. Arginase 1 competes with iNOS for L-ar-
ginine and thus can prevent nitric oxide release [33]. The
abundant representation of arginase 1 in our EST dataset
led us to test whether this gene was indeed upregulated in
vivo as a result of exposure to a Th2 inducing nematode
parasite. B. malayi were implanted into the peritoneal cav-
ity of WT and IL-4-/- C57BL/6 mice and the expression of
arginase 1 assessed in the recovered PEC. Consistent with
the observation that the addition of IL-4 in vitro could in-
duce arginase 1 [29,32,33], the lack of IL-4 in vivo prevent-
ed a significant upregulation of arginase1 over that found
in resident peritoneal cells (Figure 1A). These experiments
were repeated with F4/80+ macrophages purified with
magnetic beads (Figure 1B). The results with purified mac-
rophages were directly comparable to the results with to-
tal PEC verifying that macrophages were the source of
upregulated arginase 1.
Although IL-13 has also been shown to induce arginase 1
upregulation [29,32] in vitro, the clear phenotypic differ-
ence between IL-4 deficient mice and WT mice suggests
that IL-13 could not compensate in vivo for IL-4 in the in-
duction of arginase 1 at least in C57BL/6 mice. Since the
induction of arginase 1 is one of the clearest indicators of
alternative activation [2,11], these results were consistent
with our designation of NeMφ as 'alternatively activated'.
Our findings were also consistent with a recent study
demonstrating that type 2 cytokines regulate arginase pro-
duction during helminth infection [34]
Identification of IL-4-regulated NeMφ genes using expres-
sion arrays
Although the EST strategy was very informative about the
most abundantly expressed genes in NeMφ, we wished
also to identify IL-4 dependent genes that are transcribed
at lower levels. We therefore compared expression of 1176
known mouse genes using the Clontech Mouse 1.2 Atlas
Array. The array contains a broad range of well-character-
ized genes involved in cellular pathways and functions,
including cytokines, chemokines and associated receptors
[http://atlas.clontech.com]. In order to distinguish be-
tween genes upregulated during the recruitment/matura-
tion process and those whose expression was specific for
parasite infection, we compared WT thioglycollate elicited
macrophages with NeMφ (Figure 2A). We then compared
gene expression in NeMφ derived from IL-4 deficient mice
and WT mice (Figure 2B). From this approach we hoped
to identify genes whose expression is altered by nematode
infection in an IL-4 dependent manner.
Of the 1176 genes on the array, 141 genes were expressed
by at least one of the macrophage populations. The ex-
pression pattern of the majority of genes found on the
Mouse 1.2 Atlas Array was very similar between the 3 dif-
ferent macrophage populations. However, exceptions in-
cluded genes that are upregulated by parasite infection but
are apparently not IL-4 dependent such as IL-6 (Figure 2A
Table 1: Abundantly expressed genes in NeMφ
No. of clones % of dataset GenBank Match (accession no.)
69 10.60 Ym1/ECF-L (BAA13458)
13 1.99 FIZZ1/RELM-α (NP_065255)
9 1.38 Cytoskeletal gamma-actin (NP_033739)
8 1.23 Arginase 1 (NP_031508)
7 1.07 Cytochrome oxidase subunit 1 (AB042432)
7 1.07 EF-1-ALPHA-1/EF-TU (P20001)
7 1.07 Serum amyloid A3 (NP_035445)
4 0.61 Sp-alpha (AF018269)
3 0.46 B(2)-microglobulin (M84367)
3 0.46 Fibronectin (P11276)
3 0.46 40 kDprotein (1405340A)
3 0.46 ATP synthase F0 subunit 6 (NP_008113)
3 0.46 C4 complement (M11789)
3 0.46 acidic ribosomal phosphoprotein PO (NP_031501)
3 0.46 Fc gamma receptor III (AF197930)
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& 2B & 2D). The most notable observation was that sever-
al pro-inflammatory cytokines and chemokines such as
MIP-1α, MIP-1β and MIP-2 were more highly expressed in
the IL-4-deficient NeMφ relative to WT NeMφ (Figure 2C
& 2D). As a confirmation of the results observed on the ar-
ray, expression levels of several differentially expressed
genes were further analyzed by real-time PCR. RNA was
obtained from F4/80+ macrophages derived from WT and
IL-4-/- mice and both resident macrophages and NeMφ
were assessed (Figure 2D). These results confirmed that
the capacity to produce several proinflammatory cy-
tokines has been abolished in alternatively activated mac-
rophages recruited under Th2 conditions. The
suppression of proinflammatory cytokines is an IL-4 de-
pendent process, since macrophages recruited in IL-4 de-
ficient mice have not suppressed gene expression as
effectively as the WT mice. Some genes, such as Mφ plas-
minogen activator inhibitor 2 and P-selectin glycoprotein
ligand 1, which appeared by array analysis to be differen-
tially regulated, failed to show differences on subsequent
real-time PCR analysis.
Few genes were identified that were upregulated in the WT
macrophages compared to the IL-4 deficient macrophages
and were specific for parasite infection. This is probably
due to a bias in our knowledge (and thus on the array) to-
wards genes expressed in classically activated macrophag-
es in comparison to alternative activation pathways and
associated factors. Indeed, many of the abundantly ex-
pressed genes from our EST project were not represented
on the Mouse 1.2 Atlas Array. Hence alternative strategies
are necessary for the identification of novel genes that
could be involved in alternative activation.
Comparative analysis of suppressive vs non-suppressive IL-
4 deficient macrophages
In order to identify novel IL-4 dependent genes in the sup-
pressive NeMφ, a subtractive hybridization library was
constructed, using biotinylated RNA from IL-4-/- NeMφ to
remove commonly expressed genes found in both WT and
IL-4-/- populations. A total of 5760 primary recombinants
were recovered. The library was gridded onto nylon mem-
branes and was differentially screened for IL-4 dependent
genes by probing separate membranes with cDNA from
WT and IL-4-/- NeMφ. Of the 288 clones selected for fur-
ther sequencing analysis, 66 yielded sequences greater
than 150 bp. These were clustered and analyzed as de-
scribed in the methods. Sequences with significant simi-
larity to known genes are shown in Table 2.
The most abundantly expressed clone (37.9%) in the sub-
tractive library was the second most abundantly expressed
clone (2%) in the suppressive NeMφ cDNA library. This
gene is identical to recently described genes called FIZZ1
[25] and RELM-α [23]. Analysis of the mouse EST se-
quences in dbEST revealed that expression of FIZZ1/
RELM-α was much more highly represented in our NeMφ
EST dataset (13/651) than in any other tissue type.
To confirm that FIZZ1/RELM-α was regulated by IL-4 in vi-
vo, we compared the expression in PEC recovered from
WT or IL-4-/- mice implanted with B. malayi using quanti-
tative real-time PCR. Consistent with the results from the
Figure 1
Arginase 1 expression is increased in response to par-
asite implant in C57BL/6 but not IL-4 -/- mice. Real-
time PCR analysis of arginase 1 expression by total cells (A)
or F4/80 purified macrophages (B) obtained from peritoneal
lavages of implanted or control mice. For the purified NeMφ,
each cDNA sample was obtained from individual mice. For
the purified control macrophages, the cDNA samples repre-
sent pooled macrophages from 5 mice. Expression levels
were measured as a percentage of β-Actin expression. Error
bars represent one SD from the mean of each analysis.
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Figure 2
Mouse array analysis and real time PCR verfication. (A) Chart of the genes that showed the highest differential expres-
sion between NeMφ and thioglycollate-recruited macrophages. Values represent the difference between the gene expression
in WT NeMφ and thioglycollate-recruited Mφ (arbitrary units). (B) Chart showing the difference between the gene expression
in WT NeMφ and IL-4 -/- NeMφ. Genes selected for real-time PCR analysis are marked with an asterisk (*). (C) An example of
a section of the Atlas array that contains MIP-1α (c), MIP-1β (d), MIP-2 (e). The left panel is probed with WT NeMφ and the
right panel with IL-4-/- NeMφ. This section also contains the genes: prothymosin beta 4 (a), insulin-like growth factor IA (b),
GADPH (f), myosin I alpha (g), and ornithine decarboxylase (h), which are all not differentially expressed. (D) Verification of
Atlas array results by real-time PCR. cDNA samples from F4/80 purified macrophages from either resident peritoneal cells
(con) or from parasite implanted mice (NeMφ) were diluted and normalized to contain equal levels of β-actin transcript (data
not shown) before quantification of the different genes. Expression levels are shown in arbitrary units that are based on a com-
parison with β-actin expression (designated as 10,000 units). The results shown represent the mean values of 2 experiments
with independent sources of experimental macrophage RNA.
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subtractive hybridization, the lack of IL-4 in vivo prevent-
ed a significant upregulation of FIZZ1/RELM-α (Figure 3A
& 3B). Expresssion was further analyzed using F4/80 puri-
fied macrophages. A 40-fold induction of gene expression
at the level of mRNA, was found in WT NeMφ though ex-
pression remained basal in IL-4-/- NeMφ (Figure 3C).
Apart from FIZZ1/RELM-α, the acute phase protein SAA3
was the most abundantly represented cluster in the sub-
tractive library dataset (Table 2). We are currently investi-
gating the implications of its production by alternatively
activated macrophages. Also, six novel sequences were
identified that had not been previously described in other
EST projects as well as six genes sequences seen previously
in other EST surveys but with no functional identification.
We are currently in the process of characterizing these
novel gene products.
Discussion
In this study, using NeMφ as a source of alternatively acti-
vated macrophages, we have identified novel "marker"
genes that will be important in defining these cells in in-
flammatory responses in vivo. Our data also contributes to
the evidence that genes identified in vitro (e.g. arginase)
are expressed at elevated levels during Th2 mediated in-
flammation. Further, we have identified novel genes that
could play important biological roles in the function of al-
ternatively activated macrophages.
A key observation from our EST analysis was the high rep-
resentation of relatively few transcripts. Our analysis
would suggest that transcriptional activity of these macro-
phages is biased to relatively few genes that encode for se-
creted proteins not previously associated with
macrophage function. Almost 10% of the transcripts in
our alternatively activated macrophages encoded for a re-
cently recognized eosinophil chemotactic factor termed
Ym1/ECF-L. In subsequent analysis, we have found that
Ym1/ECF-L expression can be induced in macrophages by
the secretion of a nematode homologue of macrophage
migration inhibitory factor (MIF) [17]. These data suggest
that macrophages can act as intermediaries in the recruit-
ment of eosinophils to the site of parasite residence.
Futher, the extraordinarily high levels of Ym1 expression
by NeMø suggest the possibility that this molecule, a chi-
tin-binding protein [28], may also act as an effector mol-
ecule through direct interaction with chitin-containing
pathogens.
One of the exciting findings to arise from this analysis was
the discovery of a novel cysteine rich gene (FIZZ1/RELM-
α) that was the second most abundantly expressed gene
representing 2% of the NeMφ library. Two very recent un-
related publications have described this gene in entirely
different contexts. Holcomb et al. demonstrated expres-
sion of this gene product in the bronchoalveolar lavage
fluid of mice with OVA-induced pulmonary inflamma-
tion and termed it FIZZ1 (for found in inflammatory
zone) [25]. In vitro studies showed that FIZZ1 could in-
hibit the nerve growth factor-mediated survival of rat neu-
rons, and thus it may modulate neuron function in the
lungs and act to control the local tissue response to aller-
Table 2: Genes identified in subtractive NeMφ cDNA library
No. of sequenced clones % of total sequenced clones GenBank Match (accession no.)
25 37.88 FIZZ1/RELM-α (NP_020509)
10 15.15 Serum amyloid A3 (NP_011315)
2 3.03 Similar to Rat RNA polymerase II transcription factor SIII or elongin B (L42855)
2 3.03 Similar to extracellular proteinase inhibitor (BC002038)
2 3.03 Metallopanstimulin 1 (NM_001030)
1 1.51 Inhibitor of DNA binding 2 (BC006921)
1 1.51 Adipocyte differentiation-related protein (M93275)
1 1.51 Methallothionein-1 gene transcription activator (AA146152)
1 1.51 Ring-box 1 or Rbx1 (NM_019712)
1 1.51 Cyclophilin (X52803)
1 1.51 Thrombospondin (M62470)
1 1.51 Ym1/ECF-L (D87757)
1 1.51 Cellular apoptosis susceptibility gene (AF301152)
1 1.51 Thymosin beta-4 (X16053.1)
1 1.51 H3 histone (BC002052)
1 1.51 CD9 antigen (NM_007657)
1 1.51 Ribosomal protein S29 (NM_009093.1)
1 1.51 16S ribosomal RNA (AY011146)
BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/7
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gic inflammation. Strikingly, Holcomb et al. did not find
the expression of this protein in the alveolar macrophages
of the inflamed lung.
FIZZ1 is a member of a family of tissue-specific genes with
high similarity to resistin, termed 'resistin like molecules'
(RELM) [23]. Resistin was first described as a protein pro-
duced by adipocytes that can antagonize insulin action
and thus may be an important link between diabetes and
obesity [24]. FIZZ1 is identical to RELM-α, a gene also ex-
pressed in white adipose tissue, as well as mammary tissue
and tongue. Our results add a significant new dimension
to the understanding of the biological role of FIZZ1/
RELM-α by demonstrating that it is produced by activated
macrophages and its upregulation is crucially dependent
on IL-4.
It is interesting to note that the FIZZ/RELM gene family
may consist of genes that are highly induced upon expo-
sure of cells to exogenous stimuli. The majority of the
mouse EST sequences submitted to dbEST thus far are
from cDNA libraries made from normal tissues and there-
fore many interesting genes that are induced as a result of
immune stimulation in vivo have not been identified. The
expression of both Ym1 and FIZZ by alternatively activat-
ed macrophages in vivo is validated by recent unpublished
data with phospholipase-C-deficient T. brucei. In these
mouse studies, Ym1 and FIZZ1 were identified in macro-
phage populations isolated during the late stage of infec-
tion where Th2 responses dominate but not from
classically activated macrophages found early in infection
(G. Hassanzadeh, personal communication).
SAA3 was highly represented in both the NeMφ library
and the subtractive library. Serum amyloid A proteins are
type1 acute phase proteins that are rapidly synthesized
following acute inflammation as a result of increased tran-
scription. The regulation of the mouse SAA3 gene expres-
sion has been especially well studied [35–37]. Although it
has been shown to be produced by macrophages [38] and
is upregulated by such pro-inflammatory factors as LPS,
IL-1 and IL-6 [35,37,39], SAA3 is also induced by gluco-
corticoids and can be inhibited by IFN-γ [40]. Interesting-
ly, it has recently been shown that NFkB is involved in
activation of SAA3 transcription [36]. Although this gene
is upregulated under "classical" inflammatory conditions,
we have found a strong representation of this gene in an
IL-4 dependent manner under "alternative" activation
conditions. This suggests that there is a category of genes
that are upregulated as a result of macrophage activation
under any inflammatory conditions, which are distinct
from genes that are upregulated only in response to "clas-
sical" or "alternative" activation conditions. It further em-
phasizes that macrophage subpopulations may not fit
neatly into these activation categories and are likely to
represent a wide spectrum of phenotypes.
It is perhaps surprising that there was not a higher repre-
sentation of chemokines and cytokines in the EST dataset.
The only notable chemokine found was C10, which has
also been previously described as an IL-4 dependent gene
Figure 3
FIZZ1/RELMα expression is increased in response to
parasite implant in C57BL/6 but not IL-4 -/- mice.
Semiquantitative RT-PCR of FIZZ1/RELMα and β-actin was
performed on total RNA samples from the peritoneal lavages
of individual mice (A). Real Time PCR analysis of FIZZ1
expression by total cells (B) or F4/80 purified macrophages
(C) obtained from peritoneal lavages of implanted or naïve
control mice. For the purified NeMφ, each cDNA sample was
obtained from individual mice. For the purified control mac-
rophages, the cDNA samples represent pooled macrophages
from groups of 2 or 3 mice for a total of 5 mice per control
group. Expression levels were measured as a percentage of
β-actin expression. Error bars represent one SD from the
mean.
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in macrophages [41]. The macrophages we observe may
be representative of cells found in the later stages of
chronic inflammation and the failure to observe signifi-
cant cytokine or chemokine responses may be due to tem-
poral effects; the expression of these effector molecules
may have been and gone. The array analysis suggests that
IL-4 specifically downregulates some pro-inflammatory
chemokines such as MIP-1α, MIP-1β and MIP2. Downreg-
ulation of these chemokines has been previously observed
[42,43] and this along with reduced iNOS expression has
led to the assumption that alternatively activated macro-
phages are predominantly anti-inflammatory in function
[11]. However, it is important to consider that these mac-
rophages are found in highly inflammatory settings and
may themselves be involved in promoting Th2-mediated
pathology seen in both allergy and helminth infection.
For example, increased expression of arginase 1 is associ-
ated with collagen deposition and other fibrogenic fea-
tures [32]. This may be directly relevant to the pathology
of filarial infection where elephantiasis is associated with
infiltrates of macrophages and the deposition of thick col-
lagen fibre bundles [44]. Consistent with this are the re-
cent findings by Hesse et al. that arginase activated by type
2 cyokines plays a pivotal role in the granulomatous pa-
thology in mice infected with Schistosoma mansoni[34].
Conclusions
The role of alternatively activated macrophages is still far
from clear but these gene expression studies suggest that
their designation as anti-inflammatory cells may not be a
fully accurate reflection of their function. The high level
expression of Ym1 suggests that alternatively activated
macrophages may play a role in eosinophil chemotaxis
and thus promote rather than prevent inflammation. Fur-
ther, Ym1 is a molecule involved in crystal deposition
[45], a phenomenon with no known function but which
may have the potential to directly damage tissues [46].
The IL-4 dependent expression of FIZZ1/RELM-α suggests
the possibility that these macrophages can regulate neuro-
immunological cross-talk. These hypotheses remain to be
tested and we are currently trying to establish the in vivo
functional roles of Ym1/ECF-L and FIZZ1/RELM-α. Since
these two genes have also recently been shown to be
strongly induced in pulmonary inflammation, it suggests
that "alternatively" activated macrophages are key effector
cells in mediating many different features of Th2 associat-
ed inflammation.
Materials and methods
Preparation of in vivo derived alternatively activated mac-
rophages
For all experiments, mice used were 6–8 week old male
C57BL/6, either wild type (WT) or genetically deficient for
IL-4 or IL-5. C57BL/6 IL-4 deficient (IL-4-/-) breeding pairs
were purchased from B&K Universal Ltd. (North Humber-
side, UK) with permission of the Institute of Genetics,
University of Cologne. C57BL/6 IL-5 deficient (IL-5-/-)
mice were the kind gift of Prof. Manfred Kopf (Basel, Swit-
zerland). B. malayi adult parasites were removed from the
peritoneal cavity of infected jirds purchased from TRS
Laboratories (Athens, GA) or maintained in house. Mice
were surgically implanted intra-peritoneally (i.p.) with 6
live adult female B. malayi. Three weeks later the mice
were euthanized by cardiac puncture and peritoneal exu-
date cells (PEC) were harvested by thorough washing of
the peritoneal cavity with 15 ml of media (RPMI). Macro-
phages were purified by isolating adherent cells or by
magnetic bead sorting as indicated in the text. When
checked by flow cytometry, purification of macrophages
by adherence typically yielded 80–85% F4/80+ cells,
whereas magnetic bead sorting yielded 90–95% F4/80+
cells. Before magnetic bead cell purification, PEC were
passed through a 70µm cell strainer and purified by cen-
trifugation over Histopaque (Sigma) in order to remove
any microfilariae. F4/80+ macrophages were purified with
biotin conjugated F4/80 (rat IgG2b; Caltag) and Strepta-
vidin Microbeads (Miltenyi Biotec), with either MS+ or
VS+ columns in conjunction with MiniMacs or VarioMacs
magnet (Miltenyi Biotec). Macrophage purity was con-
firmed by both flow cytometry and cytospin analysis.
cDNA library construction and EST analysis
Total RNA from magnetically purified macrophages, ex-
tracted using RNAStat60 (Biogenesis), was used to synthe-
size cDNA and unidirectionally cloned into the pCMV-
Script plasmid vector, using the cDNA library construc-
tion kit (Stratagene, CA). Single clones from the unampli-
fied library were picked at random and the cDNA inserts
were amplified using vector primers T3 and T7. Aliquots
of the amplified PCR products were checked by agarose
gel and inserts greater than 200 bp were selected for se-
quencing. PCR products were prepared for sequencing us-
ing shrimp alkaline phosphatase and exonuclease I
(Amersham Pharmacia Biotech Ltd, Sweden) [47]. Inserts
were sequenced using the 5' vector primer SAC
(GGGAACAA AAGCTGGAG) and ABI Big DYE termina-
tors (Perkin Elmer Corporation, CT). Sequencing reac-
tions were analysed using an ABI 377 automated
sequencer.
Bioinformatics
Processing of ABI trace files was carried out using PHRED
[48] (for basecalling) and cross_match [49] (for vector
trimming). Only sequences 150 bp or longer were submit-
ted to dbEST and used in subsequent analyses. Sequences
>=150 bp in length were clustered on the basis of se-
quence similarity using an in-house program (Parkinson
et al., unpublished). Clusters of sequences (which usually
derive from one gene) were assembled into contigs using
the program CAP3 [50].
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cDNA expression array analysis
Transcripts from the RNA extracted from WT and IL-4-/-
F4/80+ magnetically purified NeMφ were PCR amplified
from cDNA tagged at the 5' and 3' ends during reverse
transcription using the Generacer kit (Invitrogen). cDNA
probes from thioglycollate elicited macrophages were
generated as above, but macrophages were purified by ad-
herence instead of using magnetic beads. The resulting
cDNA probes were labelled with 33P and hybridized to
separate Mouse 1.2 Atlas Array (Clontech) nylon mem-
branes. The hybridization signal was quantified using Im-
ageQuant Mac version 1.2. Comparison of signals from
the positive control genes on the array indicated that the
labeling intensities of the cDNA probes from the different
macrophage populations were comparable. Expression
values for individual genes were calculated in arbitrary
units relative to the strongest positive control hybridiza-
tion signal.
Subtractive library construction
Total RNA (1 µg) from F4/80 purified peritoneal macro-
phages from B. malayi implanted WT mice was converted
into 1st strand cDNA using the Clontech SMART system.
After synthesis of first strand cDNA from WT macrophag-
es, 2 rounds of subtractive hybridization were undertaken
with 20 µg RNA from peritoneal macrophages of IL-4-/-
mice infected with B. malayi, using the Invitrogen 'Sub-
tractor kit'. After 2 rounds of subtractive hybridization
and phenol-choloroform extraction, the remaining single
stranded cDNA was PCR amplified for 25 cycles. The PCR
products were then size fractionated and fractions repre-
senting different size PCR products were cloned separately
into the eukaryotic expression vector (pcDNA3.1/V5/His-
TOPO) (Invitrogen). The ligated plasmids were trans-
formed into XL-10 gold ultracompetent cells (Stratagene).
Subtractive library screen
5760 clones were gridded in duplicate onto a 22.2 × 22.2
cm nylon filter. cDNA from B. malayi recruited Mφ from
WT and IL-4-/- mice were labeled with DIG-High Prime
(Roche) and hybridized to separate nylon filters at 65°C.
The filters were imaged using a Fuji LAS1000 and the re-
sultant images were analysed using ArrayVision 4.3 (Im-
aging Research Inc.). Two hundred and eighty-eight
clones showing the greatest differential expression in WT
Mφ were selected for subsequent analysis and sequenced
by MWG-Biotech. The sequences were subjected to the
same bioinformatics analyses as the EST sequences (see
above).
Quantitative RT-PCR analysis
Total RNA was extracted in RNAStat60 (Biogenesis) and
single-stranded cDNA was synthesised using MMLV re-
verse transcriptase (Stratagene). Relative quantification of
the expression of the genes of interest was measured by
real-time PCR, using the LightCycler (Roche Molecular Bi-
ochemicals). PCR amplifications were performed in 10 µl,
containing 1 µl cDNA, 4 mM MgCl2, 0.3 µM primers and
the LightCycler-DNA SYBR Green I mix. The reaction was
performed in the following conditions: 30 s denaturation
at 95°C, 5 s annealing of primers at 55°C and 12 s elonga-
tion at 72°C, for 40–60 cycles. The fluorescent DNA bind-
ing dye SYBR Green was monitored after each cycle at
86°C. Five serial 1:5 dilutions of a positive control sample
of cDNA were used as a standard curve in each reaction,
and the expression levels of the genes of interest were
measured as a percentage of β-Actin expression. Semi-
quantitative PCR was carried out using Taq polymerase
(Qiagen) for 30 cycles. PCR products were electro-
phoresed on 1% agarose gels and visualised by ethidium
bromide staining. Primers for RT-PCR analysis were: β-Ac-
tin: TGGAATCCTGTGGCATCCATGAAAC and TAAAACG
CAGCTCAGTAACAGTCCG; product size 300 bp. FIZZ1:
GGTCCCAGTGCATATG GATGAGACCATAGA and CAC-
CTCTTCACTCGAGGGACAGTTGGCAGC; product size
300 bp.
List of abbreviations
NeMφ: Nematode elicited macrophages, PEC: Peritoneal
exudate cells; WT: wild type
Authors' contributions
Author 1 (PL) developed the approaches used in this
study, constructed the libraries, coordinated the sequenc-
ing, performed the arrays, and drafted the manuscript. Au-
thor 2 (MGN) performed real time PCR analysis in this
paper, assisted with the arrays and contributed to the anal-
ysis of the data and writing of the manuscript. Author 3
(JP) performed the bioinformatics. Author 4 (DG) helped
with library construction and development of approach-
es. Author 5 (MLB) gave essential advice on development
of the approaches and assisted with the bioinformatics.
Author 6 (JEA) supervised the studies, participated in their
design, contributed to the analysis and finalised the man-
uscript for publication.
Acknowledgements
We thank Ian Dransfield and Rick Maizels for helpful discussion and review 
of the manuscript. We thank Yvonne Harcus for invaluable technical assist-
ance. This work was supported in part by a Wellcome Trust Prize Fellow-
ship awarded to P Loke
References
1. Glass CK, Witztum JL: Atherosclerosis. the road ahead. Cell
2001, 104:503-16
2. Allen JE, Loke P: Divergent roles for macrophages in lymphatic
filariasis. Parasite Immunology 2001, 23:345-352
3. Kiefer R, Kieseier BC, Stoll G, Hartung HP: The role of macro-
phages in immune-mediated damage to the peripheral nerv-
ous system. Prog Neurobiol 2001, 64:109-27
4. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR:
Macrophages in rheumatoid arthritis. Arthritis Res 2000, 2:189-
202
5. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of
the innate immune response. Nature 2000, 406:782-7
BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/7
Page 10 of 11
(page number not for citation purposes)
6. Reiner SL, Locksley RM: The regulation of immunity to Leishma-
nia major. Annual Review of Immunology 1995, 13:151-177
7. Weinheber N, Wolfram M, Harbecke D, Aebischer T: Phagocytosis
of Leishmania mexicana amastigotes by macrophages leads
to a sustained suppression of IL-12 production. European Jour-
nal of Immunology 1998, 28:2467-77
8. Kane MM, Mosser DM: The role of IL-10 in promoting disease
progression in leishmaniasis. J Immunology 2001, 166:1141-1147
9. Bliss SK, Butcher BA, Denkers EY: Rapid recruitment of neu-
trophils containing prestored IL-12 during microbial infec-
tion. J Immunology 2000, 165:4515-21
10. Balcewicz-Sablinska MK, Gan H, Remold HG: Interleukin 10 pro-
duced by macrophages inoculated with Mycobacterium avi-
um attenuates mycobacteria-induced apoptosis by
reduction of TNF-alpha activity. Journal of Infectious Diseases
1999, 180:1230-7
11. Goerdt S, Orfanos CE: Other functions, other genes: alterna-
tive activation of antigen-presenting cells. Immunity 1999,
10:137-142
12. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P,
Gordon S: Interleukin-13 alters the activation state of murine
macrophages in vitro: comparison with interleukin-4 and in-
terferon-gamma. European Journal of Immunology 1994, 24:1441-
1445
13. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently en-
hances murine macrophage mannose receptor activity: a
marker of alternative immunologic macrophage activation.
Journal of Experimental Medicine 1992, 176:287-292
14. Schebesch C, Kodelja V, Muller C, Hakij N, Bisson S, Orfanos CE,
Goerdt S: Alternatively activated macrophages actively inhib-
it proliferation of peripheral blood lymphocytes and CD4+ T
cells in vitro. Immunology 1997, 92:478-86
15. Loke P, MacDonald AS, Robb AO, Maizels RM, Allen JE: Alternative-
ly activated macrophages induced by nematode infection in-
hibit proliferation via cell to cell contact. European Journal of
Immunology 2000, 30:2669-2678
16. Allen JE, Lawrence RA, Maizels RM: APC from mice harboring
the filarial nematode, Brugia malayi, prevent cellular prolifer-
ation but not cytokine production. International Immunology 1996,
8:143-151
17. Falcone FH, Loke P, Zang X, MacDonald AS, Maizels RM, Allen JE: A
Brugia malayi homolog of macrophage mugration inhibitory
factor reveals an important link between macrophages and
eosinophil recruitment during nematode infection. J Immunol
2001, 167:5348-54
18. MacDonald AS, Maizels RM, Lawrence RA, Dransfield I, Allen JE: Re-
quirement for in vivo production of IL-4, but not IL-10, in the
induction of proliferative suppression by filarial parasites. J
Immunol 1998, 160:1304-1312
19. Lawrence RA, Allen JE, Gregory WF, Kopf M, Maizels RM: Infection
of IL-4 deficient mice with the parasitic nematode Brugia ma-
layi demonstrates that host resistance is not dependent on a
T helper-2 dominated immune response. J Immunol 1995,
154:5995-6001
20. Loke P, MacDonald AS, Allen JE: Antigen presenting cells recruit-
ed by Brugia malayi induce Th2 differentiation of naive CD4+
T cells. European Journal of Immunology 2000, 30:1127-1135
21. Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K: Serial
analysis of gene expression in human monocytes and macro-
phages. Blood 1999, 94:837-44
22. Suzuki T, Hashimoto S, Toyoda N, Nagai S, Yamazaki N, Dong HY,
Sakai J, Yamashita T, Nukiwa T, Matsushima K: Comprehensive
gene expression profile of LPS-stimulated human mono-
cytes by SAGE. Blood 2000, 96:2584-91
23. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY,
Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA: A family of tis-
sue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001,
98:502-6
24. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM,
Patel HR, Ahima RS, Lazar MA: The hormone resistin links obes-
ity to diabetes. Nature 2001, 409:307-12
25. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W,
Nelson C, Lowman HB, Wright BD, Skelton NJ, et al: FIZZ1, a novel
cysteine-rich secreted protein associated with pulmonary in-
flammation, defines a new gene family. EMBO J. 2000, 19:4046-
55
26. Guo L, Johnson RS, Schuh JC: Biochemical characterization of
endogenously formed eosinophilic crystals in the lungs of
mice. Journal of Biological Chemistry 2000, 275:8032-8037
27. Jin HM, Copeland NG, Gilbert DJ, Jenkins NA, Kirkpatrick RB, Rosen-
berg M: Genetic characterization of the murine Ym1 gene
and identification of a cluster of highly homologous genes.
Genomics 1998, 54:316-22
28. Owhashi M, Arita H, Hayai N: Identification of a novel eosinophil
chemotactic cytokine (ECF-L) as a chitinase family protein.
Journal of Biological Chemistry 2000, 275:1279-1286
29. Munder M, Eichmann K, Modolell M: Alternative metabolic states
in murine macrophages reflected by the nitric oxide syn-
thase/arginase balance: competitive regulation by CD4+ T
cells correlates with Th1/Th2 phenotype. J Immunol 1998,
160:5347-5354
30. Uhlar CM, Whitehead AS: Serum amyloid A, the major acute-
phase reactant. European Journal of Biochemistry 1999, 265:501-523
31. Gebe JA, Llewellyn M, Hoggatt H, Aruffo A: Molecular cloning, ge-
nomic organization and cell-binding characteristics of mouse
Spalpha. Immunology 2000, 99:78-86
32. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M:
Th1/Th2-regulated expression of arginase isoforms in
murine macrophages and dendritic cells. J Immunol 1999,
163:3771-7
33. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ: Cut-
ting edge: Stat6-Dependent Substrate Depletion Regulates
Nitric Oxide Production. J Immunol 2001, 166:2173-2177
34. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever
AW, Pearce EJ, Wynn TA: Differential regulation of nitric oxide
synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo:
granulomatous pathology is shaped by the pattern of L-ar-
ginine metabolism. J Immunol 2001, 167:6533-6544
35. Bing Z, Reddy SA, Ren Y, Qin J, Liao WS: Purification and charac-
terization of the serum amyloid A3 enhancer factor. Journal of
Biological Chemistry 1999, 274:24649-56
36. Bing Z, Huang JH, Liao WS: NFkappa B interacts with serum
amyloid A3 enhancer factor to synergistically activate
mouse serum amyloid A3 gene transcription. Journal of Biologi-
cal Chemistry 2000, 275:31616-23
37. Huang JH, Liao WS: Induction of the mouse serum amyloid A3
gene by cytokines requires both C/EBP family proteins and a
novel constitutive nuclear factor. Molecular and Cellular Biology
1994, 14:4475-84
38. Meek RL, Eriksen N, Benditt EP: Murine serum amyloid A3 is a
high density apolipoprotein and is secreted by macrophages.
Proc Natl Acad Sci USA 1992, 89:7949-52
39. Meheus LA, Fransen LM, Raymackers JG, Blockx HA, Van Beeumen JJ,
Van Bun SM, Van de Voorde A: Identification by microsequenc-
ing of lipopolysaccharide-induced proteins secreted by
mouse macrophages. J Immunol 1993, 151:1535-47
40. Ishida T, Matsuura K, Setoguchi M, Higuchi Y, Yamamoto S: En-
hancement of murine serum amyloid A3 mRNA expression
by glucocorticoids and its regulation by cytokines. Journal of
Leukocyte Biology 1994, 56:797-806
41. Orlofsky A, Wu Y, Prystowsky MB: Divergent regulation of the
murine CC chemokine C10 by Th1 and Th2 cytokines. Cy-
tokine 2000, 12:220-8
42. Flesch IE, Barsig J, Kaufmann SH: Differential chemokine re-
sponse of murine macrophages stimulated with cytokines
and infected with Listeria monocytogenes. International Immunol-
ogy 1998, 10:757-65
43. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS: Roles of
TH1 and TH2 cytokines in a murine model of allergic derma-
titis. Journal of Clinical Investigation 1999, 103:1103-11
44. Olszewski WL, Jamal S, Manokaran G, Lukomska B, Kubicka U: Skin
changes in filarial and non-filarial lymphoedema of the lower
extremities. Trop. Med. Parasitol. 1993, 44:40-4
45. Guo L, Johnson RS, Schuh JC: Biochemical characterization of
endogenously formed eosinophilic crystals in the lungs of
mice. J Biol Chem 2000, 275:8032-7
46. Feldmesser M, Kress Y, Casadevall A: Intracellular crystal forma-
tion as a mechanism of cytotoxicity in murine pulmonary
Cryptococcus neoformans infection. Infection and Immunity 2001,
69:2723-2727
BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/7
Page 11 of 11
(page number not for citation purposes)
Publish with BioMed Central  and  every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com
47. Daub J, Loukas A, Pritchard DI, Blaxter M: A survey of genes ex-
pressed in adults of the human hookworm, Necator americanus
1999, 120:171-184
48. Ewing B, Hillier L, Wendl MC, Green P: Base-calling of automated
sequencer traces using phred. I. Accuracy assessment. Ge-
nome Research 1998, 8:175-85
49. Green P: Documentation for Phrap. Genome Center, University of
Washington; 1996
50. Huang X, Madan A: CAP3: A DNA sequence assembly pro-
gram. Genome Research 1999, 9:868-77
